Gordian Capital (Singapore)’s Eli Lilly LLY Stock Holding History

Gordian Capital (Singapore)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.2K	Sell	10 -20	-67%	-$20.3K	0.02%	89
2025 Q4	$32.2K	Sell	30 -30	-50%	-$28.7K	0.04%	89
2025 Q3	$45.8K	Buy	60 +50	+500%	+$37.2K	0.06%	104
2025 Q2	$7.79K	Sell	10 -305	-97%	-$237K	0.01%	102
2025 Q1	$260K	Sell	315 -975	-76%	-$811K	0.16%	75
2024 Q4	$997K	Buy	1,290 +475	+58%	+$393K	0.52%	47
2024 Q3	$722K	Buy	815 +406	+99%	+$365K	0.27%	46
2024 Q2	$370K	Sell	409 -541	-57%	-$433K	0.21%	52
2024 Q1	$739K	Buy	+950	New	+$676K	0.55%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gordian Capital (Singapore)'s LLY Position: Q1 2026 in Review

Gordian Capital (Singapore) reduced its Eli Lilly (LLY) stake by 67% in Q1 2026, selling an estimated $20.3K and leaving 10 shares worth $9.2K. The position accounts for 0.02% of the portfolio, ranked #89.

Gordian Capital (Singapore) first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $997K in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Gordian Capital (Singapore) held 10 shares of Eli Lilly worth $9.2K as of Q1 2026.
Gordian Capital (Singapore) sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
Eli Lilly made up 0.02% of Gordian Capital (Singapore)'s portfolio in Q1 2026, its #89 holding.
Gordian Capital (Singapore) first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Gordian Capital (Singapore)'s Eli Lilly position peaked at $997K in Q4 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.